Page last updated: 2024-08-18

propylparaben and Neuroleptic Malignant Syndrome

propylparaben has been researched along with Neuroleptic Malignant Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Babini, E; Cavagna, D; Prestipino, G; Treves, S; Zorzato, F	1

Other Studies

1 other study(ies) available for propylparaben and Neuroleptic Malignant Syndrome

Article	Year
Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca(2+) release channel. British journal of pharmacology, 2000, Volume: 131, Issue:2 Topics: Animals; Antipsychotic Agents; Calcium; Dose-Response Relationship, Drug; Food Preservatives; Haloperidol; In Vitro Techniques; Neuroleptic Malignant Syndrome; Parabens; Rabbits; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum	2000

Article

Year

Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca(2+) release channel.

British journal of pharmacology, 2000, Volume: 131, Issue:2

Topics: Animals; Antipsychotic Agents; Calcium; Dose-Response Relationship, Drug; Food Preservatives; Haloperidol; In Vitro Techniques; Neuroleptic Malignant Syndrome; Parabens; Rabbits; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum

2000